Resultados de la búsqueda 571-580 of 10464 for Cycle

  1. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  2. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  3. Salud de la mujer - Mayo Clinic

    https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. Accessed Aug. 30, 2022. Welt CK. Evaluation of the menstrual cycle and ...

  4. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  5. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  6. Ensayos clínicos - Neurología

    The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

  7. Ensayos clínicos - Neurología

    The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

  8. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  9. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  10. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...